ORYZA PHARMACEUTICALS INC.
Live / Registered — Registered (as of 18 Nov 2025)
What this means for you
Registered since 18 Nov 2025. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Nov 2031: the §8 declaration of use).
Record
- Serial number
- 97009108
- Registration number
- 8026799
- Mark type
- Word mark
- Filed
- 02 Sept 2021
- Published for opposition
- 26 Aug 2025
- Registered
- 18 Nov 2025
- Next maintenance filing
- §8 declaration of use, due by 18 Nov 2031 (grace period to 18 May 2032)
- Attorney of record
- E. ANTHONY FIGG
Goods and services
- Class 042 — Scientific and technological services: Pharmaceutical research and development; Development of pharmaceutical preparations and medicines
Owner
- Oryza Pharmaceuticals, Inc., Coral Springs, FL, US
- Oryza Pharmaceuticals, Inc., Coral Springs, FL, US
- Oryza Pharmaceuticals, Inc., Coral Springs, FL, US
Board proceedings on this mark
- Ex Parte Appeal No. 97009108 — Oryza Pharmaceuticals, Inc., filed 08 Feb 2024 (Terminated)
Prosecution history
- 18 Nov 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 18 Nov 2025 — REGISTERED-PRINCIPAL REGISTER
- 31 Oct 2025 — 1(B) BASIS DELETED; PROCEED TO REGISTRATION
- 31 Oct 2025 — NOTICE OF ALLOWANCE CANCELLED
- 29 Oct 2025 — POST PUBLICATION AMENDMENT - ENTERED
- 29 Oct 2025 — ASSIGNED TO PETITION STAFF
- 23 Oct 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 23 Oct 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 21 Oct 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 22 Sept 2025 — TEAS POST PUBLICATION AMENDMENT RECEIVED
- 26 Aug 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Aug 2025 — PUBLISHED FOR OPPOSITION
- 20 Aug 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 Jul 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 22 Jul 2025 — EXAMINER'S AMENDMENT ENTERED